siRNA Design Tool

Design effective siRNA sequences for gene silencing experiments with advanced specificity and efficacy analysis.

Enter Sequence
Accession Number
Advanced Options
Enter the target gene sequence in DNA or mRNA format (A, T/U, C, G only)
Enter NCBI or Ensembl accession number to retrieve sequence automatically
Optimal range: 30-55%
Designing siRNA sequences...

Understanding siRNA Design

Small interfering RNA (siRNA) is a class of double-stranded RNA molecules that induce RNA interference (RNAi), a biological process where RNA molecules inhibit gene expression by neutralizing targeted mRNA molecules.

Key Principles for Effective siRNA Design:

  • Specificity: Minimize off-target effects by ensuring sequence uniqueness
  • GC Content: Optimal range is 30-55% for effective silencing
  • Thermodynamic Properties: Sense strand should have weaker 5' end binding than antisense strand
  • Avoidance of Motifs: Exclude sequences with known immunostimulatory motifs

Design Algorithm Parameters

Parameter Optimal Value Importance
siRNA Length 19-21 bp Standard length for RISC loading
GC Content 30-55% Affects duplex stability and specificity
5' Antisense Stability Weaker than sense 5' end Ensures proper strand selection by RISC
Avoid Internal Repeats No runs of 4+ identical bases Reduces off-target effects
3' Overhangs UU or dTdT (2 nt) Enhances Dicer processing and stability

Scoring System

Our algorithm evaluates each potential siRNA sequence based on multiple parameters:

1

Specificity Score (40%): BLAST analysis against transcriptome to minimize off-target effects

2

Efficacy Score (30%): Based on GC content, thermodynamic stability, and absence of inhibitory motifs

3

Secondary Structure (20%): Evaluation of target mRNA accessibility and siRNA self-complementarity

4

Sequence Features (10%): Position-specific nucleotide preferences and absence of immunostimulatory sequences

Applications of siRNA

  • Functional Genomics: Gene knockdown studies to determine gene function
  • Therapeutic Development: RNAi-based therapies for cancer, viral infections, and genetic disorders
  • Drug Target Validation: Confirming potential drug targets by observing phenotypic changes after knockdown
  • Pathway Analysis: Systematic knockdown of pathway components to understand signaling networks
  • Agricultural Biotechnology: Developing pest-resistant crops through gene silencing

Experimental Considerations: Always validate siRNA efficacy experimentally. Test multiple siRNAs targeting the same gene and include appropriate controls (scrambled siRNA, non-targeting siRNA, etc.). Consider using pooled siRNAs or siRNA libraries for screening applications.

Frequently Asked Questions

The standard length for siRNA is 19-21 base pairs, which is optimal for loading into the RNA-induced silencing complex (RISC). Longer sequences (27-29 bp) can be processed by Dicer into multiple siRNAs but may increase off-target effects. Our tool defaults to 19 bp with 2 nt 3' overhangs, which is the most commonly used format.

To minimize off-target effects: 1) Use BLAST analysis to ensure sequence uniqueness, 2) Avoid seed region (positions 2-8 of antisense strand) matches to unintended targets, 3) Use lower siRNA concentrations (typically 10-50 nM), 4) Consider using pooled siRNAs or modified nucleotides, and 5) Always include proper controls (non-targeting siRNA) in experiments.

Thermodynamic asymmetry refers to the difference in binding strength between the 5' ends of the two siRNA strands. The antisense strand (guide strand) should have a relatively weaker 5' end compared to the sense strand (passenger strand). This asymmetry helps ensure proper loading of the antisense strand into RISC, which is essential for target recognition and cleavage.

It is recommended to test at least 2-4 different siRNA sequences targeting different regions of the same gene. This accounts for potential differences in target site accessibility and efficacy. Testing multiple siRNAs helps confirm that observed phenotypic effects are due to specific target knockdown rather than off-target effects.

Common reasons include: 1) Inaccessible target site due to mRNA secondary structure or protein binding, 2) High GC content leading to excessive stability, 3) Immunostimulatory sequences activating innate immune responses, 4) Inefficient delivery into cells, 5) Rapid degradation of siRNA, 6) Insufficient knockdown due to high target mRNA abundance, and 7) Off-target effects masking true phenotype.